» Articles » PMID: 27095304

MiR-3188 Regulates Nasopharyngeal Carcinoma Proliferation and Chemosensitivity Through a FOXO1-modulated Positive Feedback Loop with MTOR-p-PI3K/AKT-c-JUN

Overview
Journal Nat Commun
Specialty Biology
Date 2016 Apr 21
PMID 27095304
Citations 98
Authors
Affiliations
Soon will be listed here.
Abstract

The biological role of miR-3188 has not yet been reported in the context of cancer. In this study, we observe that miR-3188 not only reduces cell-cycle transition and proliferation, but also significantly prolongs the survival time of tumour-bearing mice as well as sensitizes cells to 5-FU. Mechanistic analyses indicate that miR-3188 directly targets mTOR to inactivate p-PI3K/p-AKT/c-JUN and induces its own expression. This feedback loop further suppresses cell-cycle signalling through the p-PI3K/p-AKT/p-mTOR pathway. Interestingly, we also observe that miR-3188 direct targeting of mTOR is mediated by FOXO1 suppression of p-PI3K/p-AKT/c-JUN signalling. In clinical samples, reduced miR-3188 is an unfavourable factor and negatively correlates with mTOR and c-JUN levels but positively correlates with FOXO1 expression. Our studies demonstrate that as a tumour suppressor, miR-3188 directly targets mTOR to stimulate its own expression and participates in FOXO1-mediated repression of cell growth, tumorigenesis and NPC chemotherapy resistance.

Citing Articles

HIF-1α Mediated Regulation of Glioblastoma Malignant Phenotypes through CD47 Protein: Understanding Functions and Mechanisms.

Tan Q, Li F, Wang J, Zou Y, Tang Y, Cai Y J Cancer. 2025; 16(3):750-764.

PMID: 39781344 PMC: 11705044. DOI: 10.7150/jca.101050.


SPINK13 acts as a tumor suppressor in hepatocellular carcinoma by inhibiting Akt phosphorylation.

Lun Y, Sun J, Wei L, Liu B, Li Z, Dong W Cell Death Dis. 2024; 15(11):822.

PMID: 39537605 PMC: 11561306. DOI: 10.1038/s41419-024-07214-3.


A novel proteomic prognostic signature characterizes the immune landscape and predicts nasopharyngeal carcinoma prognosis.

Zhu L, Duan W, Peng L, Shan X, Liu Y, Huang Z Heliyon. 2024; 10(19):e37897.

PMID: 39386833 PMC: 11462186. DOI: 10.1016/j.heliyon.2024.e37897.


Non-Muscle Myosin II A: Friend or Foe in Cancer?.

Feroz W, Park B, Siripurapu M, Ntim N, Kilroy M, Sheikh A Int J Mol Sci. 2024; 25(17).

PMID: 39273383 PMC: 11395477. DOI: 10.3390/ijms25179435.


MiRNA signatures in nasopharyngeal carcinoma: molecular mechanisms and therapeutic perspectives.

Chen Y, Lin T, Tang L, He L, He Y Am J Cancer Res. 2024; 13(12):5805-5824.

PMID: 38187072 PMC: 10767356.


References
1.
Haslehurst A, Koti M, Dharsee M, Nuin P, Evans K, Geraci J . EMT transcription factors snail and slug directly contribute to cisplatin resistance in ovarian cancer. BMC Cancer. 2012; 12:91. PMC: 3342883. DOI: 10.1186/1471-2407-12-91. View

2.
Miska E . How microRNAs control cell division, differentiation and death. Curr Opin Genet Dev. 2005; 15(5):563-8. DOI: 10.1016/j.gde.2005.08.005. View

3.
Que T, Song Y, Liu Z, Zheng S, Long H, Li Z . Decreased miRNA-637 is an unfavorable prognosis marker and promotes glioma cell growth, migration and invasion via direct targeting Akt1. Oncogene. 2015; 34(38):4952-63. DOI: 10.1038/onc.2014.419. View

4.
Ahmed F . Microarray RNA transcriptional profiling: part II. Analytical considerations and annotation. Expert Rev Mol Diagn. 2006; 6(5):703-15. DOI: 10.1586/14737159.6.5.703. View

5.
Yu X, Zhen Y, Yang H, Wang H, Zhou Y, Wang E . Loss of connective tissue growth factor as an unfavorable prognosis factor activates miR-18b by PI3K/AKT/C-Jun and C-Myc and promotes cell growth in nasopharyngeal carcinoma. Cell Death Dis. 2013; 4:e634. PMC: 3674361. DOI: 10.1038/cddis.2013.153. View